Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/Ib Study of Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide and/or Bendamustine

NCT02996773 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT02996773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02996773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/Ib Study of Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide and/or Bendamustine
Lead sponsor
University of Arizona
Phase
Phase 1
Overall status
Completed
Start date
November 29, 2016
Completion date
August 1, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myelogenous leukemia, burkitt lymphoma, chronic myelogenous leukemia, gray zone lymphoma, high risk undifferentiated acute leukemia, large cell lymphoma, lymphoma, follicular, lymphoma, hodgkin, lymphoma,non-hodgkin, mantle-cell lymphoma, marginal zone lymphoma, myelodysplastic syndromes